Advertisement Lily to support international tuberculosis programs - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Lily to support international tuberculosis programs

The International Federation of Red Cross and Red Crescent Societies and Eli Lilly and company have signed an agreement which will allow an eight-fold increase in the number of International Federation-supported programs to fight multidrug-resistant tuberculosis over the next four years.

Lilly’s $1.6 million contribution will finance programs between 2008 and 2011. In 2008 alone, the International Federation will expand its support to 10 additional MDR-TB programs in Kazakhstan, Uzbekistan, Romania, Georgia, Kenya, Mozambique and South Africa, for a total of 14 MDR-TB programs.

The first phase of the International Federation and Lilly MDR-TB Program was implemented from 2004 to 2007 in three pilot countries.

Sidney Taurel, chairman and CEO of Lilly, said: “We will continue to learn lessons from existing programs and improve our initiatives to best serve those suffering from MDR-TB, and to best prevent its spread. We are committed, for the long-term, to triumph over the re-emergence of TB and MDR-TB.”